Clinical trial
A Phase 1, Open- Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate
NCT01884636 is registered in ClinicalTrials.gov with Astellas Pharma Global Development, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Open- Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- March 31, 2013
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy subjects, pharmacokinetics of 7-hydroxymethotrexate, pharmacokinetics of isavuconazole, pharmacokinetics of methotrexate